Doug Hampton

ACCORD et HIPRA concluent un accord de distribution exclusif pour commercialiser le vaccin COVID-19 (BIMERVAX®) de HIPRA au Royaume-Uni

by

BIMERVAX® : une dose de rappel d’un vaccin bivalent à base de protéines recombinantes permet d’immuniser les personnes âgées de plus de 16 ans LONDRES et GERONE, Espagne, 4 août 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord) et HIPRA ont annoncé aujourd’hui qu’ils ont conclu un accord de distribution exclusif pour commercialiser le vaccin COVID-19 de HIPRA … Read more

Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial

by

The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating hunger. Aardvark’s Phase 2 trial of oral ARD-101 in young adults with PWS is now open for enrollment of additional subjects. SAN DIEGO, Aug. 3, 2023 /PRNewswire/ — Aardvark Therapeutics, … Read more

Adoption of Eco-Friendly Decontamination Products Gaining Momentum

by

DUBLIN, Aug. 2, 2023 /PRNewswire/ — The “Bio Decontamination Market by Product (Equipment, Consumables), Agent (Hydrogen Peroxide, Chlorine Dioxide, Nitrogen Dioxide), Type (Room Decontamination, Chamber Decontamination), End user (Hospital & Healthcare facilities) – Global Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering. The global bio decontamination market is projected to reach USD 339 million … Read more

DAH Notifies Individuals of Data Security Incident

by

BONITA SPRINGS, Fla., July 31, 2023 /PRNewswire/ — On or about June 1, 2023, Discovery at Home (DAH) became aware that a team member had fallen victim to a phishing email scheme which resulted in the inadvertent transmittal of personal health information via unencrypted e-mail to an unauthorized third-party sender. DAH has worked diligently to determine … Read more

Das erste europäische Netzwerk zur Durchführung dezentraler klinischer Studien

by

Mit dem Ziel, die Akzeptanz von DCTs in Europa zu erhöhen und Sponsoren auf dem Weg in die Welt virtueller Studien zu unterstützen, , ist das Unternehmen auf dem besten Weg, im September 2023 eine europäische DCT-Lösung auf den Markt zu bringen. LIVERPOOL, Vereinigtes Königreich, 31. Juli 2023 /PRNewswire/ — Mit der Übernahme von emovis, … Read more

SAN DIEGO INDEPENDENT ORTHOPEDIC MEDICAL GROUP EXPANDS ITS PRESENCE

by

SAN DIEGO, July 30, 2023 /PRNewswire/ — Synergy Orthopedic Specialists, the largest independent physician-owned, physician-led medical practice in San Diego, continues its growth in San Diego and Riverside Counties by merging Thomas W. Harris, MD’s worker’s compensation medical practice. Additionally, the esteemed group proudly welcomes two new exceptional physicians, Pascual Dutton, MD, and Scot Youngblood, … Read more

Herbalife Takes Over the Streets of San Antonio to Host Fit Hour to Inspire People to Live Their Best Lives Through Health and Fitness

by

Proceeds from the event will benefit the Herbalife Nutrition Foundation SAN ANTONIO, July 29, 2023 /PRNewswire/ — Herbalife, a premier health and wellness company and community, took to Market Street today to host its Fit Hour, a live workout for approximately 5,000 Herbalife distributors from across the United States to encourage people to get up … Read more

Immunodiagnostics Market size to grow by USD 22,669.75 million from 2022 to 2027|Increased demand for biomarker-based tests boost the market

by

NEW YORK, July 28, 2023 /PRNewswire/ — The immunodiagnostics market size is set to grow by USD 22,669.75 million between 2022 and 2027 and register an accelerating CAGR of 12%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by the way of synthesis, and … Read more

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

by

HONG KONG, Germantown, Md. and SUZHOU, China, July 27, 2023  /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the … Read more